Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices

Jin Wook Chung

Clin Mol Hepatol. 2019;25(2):181-182. Published online December 21, 2018

DOI: https://doi.org/10.3350/cmh.2018.1010

View: 5348 Download: 123 Web of Science: 2 Crossref: 2

Review

Anticoagulation in cirrhosis: a new paradigm?

Filippo Leonardi, Nicola De Maria, Erica Villa

Clin Mol Hepatol. 2017;23(1):13-21. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0110

View: 14712 Download: 810 Web of Science: 46 Crossref: 50

3

Effect of Endoscopic Sclerotherapy Using N-butyl-2-cyanoacrylate in Patients with Gastric Variceal Bleeding

Jae Woo Kim , Soon Koo Baik , Kyu Hong Kim , Hye Jeong Kim , Ki Won Jo , Jin Hon Hong , Myeong Gwan Jee , Hyun Soo Kim , Sang Ok Kwon

Clin Mol Hepatol. 2006;12(3):394-403. Published online January 1, 2000

View: 2459 Download: 27

Comparison of Terlipressin and Octreotide with Variceal Ligation for Controlling Acute Esophageal Variceal Bleeding - a Randomized Prospective Study

Sung Bum Cho , Kang Jin Park , Jung Soo Lee , Wan Sik Lee , Chang Hwan Park , Young Eun Joo , Hyun Soo Kim , Sung Kyu Choi , Jong Sun Rew , Sei Jong Kim

Clin Mol Hepatol. 2006;12(3):385-393. Published online January 1, 2000

View: 3693 Download: 162

A Prospective Study Comparing the Efficacy of Early Administration of Terlipressin and Somatostatin for the Control of Acute Variceal Bleeding in Patients with Cirrhosis

Yeon Seok Seo, M.D., Soon Ho Um, M.D., Jong Jin Hyun, M.D., Youn Ho Kim, M.D., Sanghoon Park, M.D., Bo Ra Keum, M.D., Yong Sik Kim, M.D., Yoon Tae Jeen, M.D., Hong Sik Lee, M.D., Hoon Jai Chun, M.D., Sang Woo Lee, M.D., Jai Hyun Choi, M.D., Chang Duck Kim, M.D., and Ho Sang Ryu, M.D.

Clin Mol Hepatol. 2006;12(3):373-384. Published online January 1, 2000

View: 3294 Download: 85

1 |

Viewed By 5186	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5047	MAFLD: How is it different from NAFLD?
Viewed By 5000	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3680	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3642	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search